Pete Pete
Source health

section

Finance

Markets, money, and the business of the world. Read-only — these stories don't post to Matrix.

375 stories archived

The CEO’s of Broadcom and Intel Say the Quiet Part out Loud about AI and ROI
Wolf Street Oct 12 · 4 min read

The CEO’s of Broadcom and Intel Say the Quiet Part out Loud about AI and ROI

“I think we’ve probably got everything wrong. It’s a good way, humble way to realize how little we really know about the technology we are creating.”

Salesforce Just Got a Rare Double Upgrade—What Changed?
MarketBeat Oct 12 · 6 min read

Salesforce Just Got a Rare Double Upgrade—What Changed?

Bank of America upgraded Salesforce to Buy after its planned Loops acquisition, as Agentforce revenue growth and a $25 billion buyback program bolster the stock's valuation case.

OpenAI's Revenue Scare Could Be a Big Opportunity for Investors
MarketBeat Oct 12 · 5 min read

OpenAI's Revenue Scare Could Be a Big Opportunity for Investors

OpenAI's reported $50 billion revenue run rate, below earlier estimates, raises IPO valuation questions and stirs concern over Oracle's $300 billion contract and AI compute demand.

China Still Dominates Rare Earths—These 3 U.S. Companies Could Benefit
MarketBeat Oct 12 · 4 min read

China Still Dominates Rare Earths—These 3 U.S. Companies Could Benefit

As U.S. rare earth production continues to lag China's despite recent trade talks, MP Materials, Energy Fuels and NioCorp Developments each offer investors different ways to gain exposure to domestic critical minerals.

3 REITs That May Win in a Higher Interest Rate Environment
MarketBeat Oct 12 · 5 min read

3 REITs That May Win in a Higher Interest Rate Environment

Realty Income, American Tower, and Public Storage may be positioned to benefit if Treasury yields decline, with analysts offering mixed Buy and Hold ratings on each REIT.

Insider Buying Signals Opportunity in H.B. Fuller, FocalTherics, Cardinal
MarketBeat Oct 12 · 4 min read

Insider Buying Signals Opportunity in H.B. Fuller, FocalTherics, Cardinal

Insiders at H.B. Fuller, FocalTherics, and Cardinal Infrastructure Group are buying shares, signaling potential bottoms backed by analyst price targets, institutional ownership, and growth catalysts.

Broadcom’s Anthropic Bet Gets Bigger as $60 Billion Financing Raises the Stakes
MarketBeat Oct 12 · 4 min read

Broadcom’s Anthropic Bet Gets Bigger as $60 Billion Financing Raises the Stakes

Anthropic's IPO filing reveals $161 billion in Broadcom commitments, backed by a new $60 billion debt package and AI XPV financing vehicle ahead of its planned mid-November public debut.

5 Retail Picks to Watch as the Holiday Shopping Season Nears
MarketBeat Oct 12 · 1 min read

5 Retail Picks to Watch as the Holiday Shopping Season Nears

While the retail sector trails the broader market this year, Target, Abercrombie & Fitch, Ulta Beauty, and Victoria's Secret have outperformed peers with strong earnings beats ahead of the holiday shopping season.

C.H. Robinson Bets Its AI Story on RXO—But the Market Isn't Sold
MarketBeat Oct 12 · 5 min read

C.H. Robinson Bets Its AI Story on RXO—But the Market Isn't Sold

C.H. Robinson shares fell after its $5.8 billion stock-and-cash deal to acquire RXO, as investors weigh added debt, paused buybacks, and a multiyear wait for promised synergies and EPS accretion.

3 Stocks Raise Dividends, But Which Has Room to Keep Growing?
MarketBeat Oct 12 · 5 min read

3 Stocks Raise Dividends, But Which Has Room to Keep Growing?

Accenture, Curtiss-Wright, and Starbucks all raised their dividends, with Starbucks' hike coming amid reports it explored acquiring Chipotle during its ongoing turnaround.

Google's $13 Billion Nordic Bet Points to a New Global Front in the AI Power Race
MarketBeat Oct 12 · 6 min read

Google's $13 Billion Nordic Bet Points to a New Global Front in the AI Power Race

Hyperscalers like Google are shifting AI data center buildouts to Finland and Norway, drawn by surplus power, stable grids, clear permitting and local support.

What the Sandals Deal Means for Royal Caribbean's Next Leg of Growth?
MarketBeat Oct 12 · 5 min read

What the Sandals Deal Means for Royal Caribbean's Next Leg of Growth?

Royal Caribbean's $3 billion Sandals resort stake has driven shares up amid analyst optimism, though debt and fuel costs pose risks as the cruise business remains strong heading into 2027.

Did Promo Spending Actually Win Back Bettors for These 3 Gambling Stocks?
MarketBeat Oct 12 · 5 min read

Did Promo Spending Actually Win Back Bettors for These 3 Gambling Stocks?

Facing prediction-market pressure, Flutter, Las Vegas Sands, and Penn Entertainment took different promotion strategies in 2026, with mixed stock results and only Penn's marketing pullback gaining investor favor.

Applied Digital Plugs Into Hyperscaler Buyout Bids
MarketBeat Oct 12 · 6 min read

Applied Digital Plugs Into Hyperscaler Buyout Bids

Applied Digital (APLD) secured a site for a 1-gigawatt AI campus in Finland, adding to its $36 billion contracted revenue backlog and 1.41 gigawatts of domestic leased IT load.

3 Stocks Chopped in Half: Why These Drops May Be Structural, Not a Dip
MarketBeat Oct 11 · 5 min read

3 Stocks Chopped in Half: Why These Drops May Be Structural, Not a Dip

Lululemon, Trade Desk, and Charter Communications shares have each fallen over 50% amid structural declines in comps, revenue growth, and subscribers, with no clear bottom yet in sight.

Home Depot and Lowe’s Hit 52-Week Lows—But Analysts Aren’t Giving Up
MarketBeat Oct 11 · 5 min read

Home Depot and Lowe’s Hit 52-Week Lows—But Analysts Aren’t Giving Up

Home Depot and Lowe's shares hit 52-week lows amid a frozen housing market, but both posted strong earnings and carry Moderate Buy ratings with notable upside targets.

Utilities Are Bouncing Back—These 2 Giants Could Signal the Next Big Sector Rally
MarketBeat Oct 11 · 5 min read

Utilities Are Bouncing Back—These 2 Giants Could Signal the Next Big Sector Rally

XLU bounced off a 52-week low near $39 as rising Treasury yields pressured utilities; NextEra Energy and Southern Company, its top holdings, show signs of a sector bottom forming.

Q3 Earnings Could Blow Past Consensus—Be Ready for What Comes Next
MarketBeat Oct 11 · 4 min read

Q3 Earnings Could Blow Past Consensus—Be Ready for What Comes Next

AI-driven demand is lifting earnings estimates and price targets across cybersecurity, semiconductor, and CPU stocks, including PANW, MRVL, AMD, and INTC, ahead of Q3 results.

Why Wall Street Expects Even More From SanDisk After Its 575% Rally
MarketBeat Oct 11 · 5 min read

Why Wall Street Expects Even More From SanDisk After Its 575% Rally

SanDisk shares have surged 575% in 2026 on AI storage demand, and analysts including Mizuho, Rosenblatt, and Arete Research keep raising price targets ahead of earnings later this month.

The Grocery Shelf Battle Is Changing—Who Comes Out Ahead?
MarketBeat Oct 11 · 5 min read

The Grocery Shelf Battle Is Changing—Who Comes Out Ahead?

Store brands are gaining unit share over national labels like McCormick as shoppers seek value, while Kroger and Walmart expand private-label lines to capture margin growth.

US Government Sold $728 Billion of Treasuries this Week. Yields at the 3-Year, 10-Year, 30-Year Auctions Highest in 20+ Years, Demand Emerges. Short-Term Yields See Rate Hike
Wolf Street Oct 11 · 7 min read

US Government Sold $728 Billion of Treasuries this Week. Yields at the 3-Year, 10-Year, 30-Year Auctions Highest in 20+ Years, Demand Emerges. Short-Term Yields See Rate Hike

The bond market is functioning again after the Fed’s interest rate repression between 2008-2022 had broken it.

3 Unique ETFs With Strong Momentum for the End of the Year
MarketBeat Oct 10 · 5 min read

3 Unique ETFs With Strong Momentum for the End of the Year

FTHF, HECO, and GTEK ETFs use niche strategies in emerging markets, hedged crypto, and smaller tech firms, each gaining 40% or more year to date in 2026.

3 Beaten-Down Biotech Stocks With Triple-Digit Upside and Big Catalysts Ahead
MarketBeat Oct 10 · 6 min read

3 Beaten-Down Biotech Stocks With Triple-Digit Upside and Big Catalysts Ahead

Inventiva, Larimar Therapeutics, and Ascentage Pharma face key drug-development milestones, with analysts assigning Buy ratings and triple-digit upside price targets to all three biotech stocks.

Schneider Just Paid Up for PTC—Is the SaaSpocalypse Overdone?
MarketBeat Oct 10 · 5 min read

Schneider Just Paid Up for PTC—Is the SaaSpocalypse Overdone?

Schneider Electric will pay about $22.6 billion for PTC at a 42% premium, its largest-ever deal, but SBGSY shares fell 16% as investors weighed integration risks and debt funding.